EGFR is positively expressed in 59 to 85% of CRC specimens, and its overexpression is closely related to clinical stage, lymph node metastasis, disease-free survival, poor overall survival, and 5-year recurrence rate [8–10]. Here, EGFR is linked to colorectal carcinoma.